CDER Index M-S
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Management, Risk -- see Risk Management
Manuals
Medical Bulletin
Medical Gases, Compressed
Medical Imaging and Drug
Development
Medication Errors
Medication Guides
MedWatch
Meetings
Metered-Dose Inhalers
Modernization Act of 1997: CDER-Related Documents
My Medicines
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Natural Disasters
- National Drug Code Directory
- Database
- Text Files
New Drugs
News Along the Pike - CDER Newsletter
News Releases
Nonprescription Products -- see Over-the-Counter (OTC) Drugs
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Offices and Divisions
Older Persons -- see Seniors
Ombudsman
Oncology Tools
Office of Oncology Drug Products
Web Wite
Organizational Information
Orphan Products
Over-the-Counter (OTC) Drugs
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Pancreatic
Insufficiency Drug Products
Patents
Patient Labeling and Risk Communication (includes Medication Guides)
Patients
PDUFA -- see Prescription Drug User Fee Act
Pediatrics
Petitions -- see Dockets
Pharmaceutical cGMPs:
A Risk-Based Approach
Pharmacoepidemiology and
Statistical Science, Office of
Pharmacogenomics -- see Genomics
Pharmacology and Toxicology Guidances
Pharmacy Compounding
Pharmacy Student Experiential
Program
Phase IV Commitments -- see Postmarketing Study
Commitments
Phone Directory, HHS
Planning, Office of
Postmarketing Study Commitments
Prescription Drug User Fee Act (PDUFA)
Prescription Drug Advertising
Presentations, CDER
Policies and Procedures (MaPPs)
Post-Marketing Surveillance and Epidemiology
Process Analytical Technologies
(PAT) Initiative
Privacy Statement and Other Information About FDA's Web Site
Problems with FDA-Regulated Products
Product Alerts and Warnings
Product Approvals
Proposed Regulations for Public Comment
Public Affairs
Public Health Alerts & Warning Letters
Publications
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Quick Index to General Subjects Related to Drug
Regulation -- see CDER Reference Guide
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Radioactive Drug Research Committee (RDRC) Program
Recalls, Market Withdrawals and Safety Alerts
Regulations
Regulatory Affairs, Office of
Regulatory Authorities, International
Regulatory and Scientific Issues Related to Developing Follow-On Protein Products
Reinvention Initiatives
Reporting Adverse Reactions and Other Problems with
Products
Reports
Research Fact Book 1997
Reviewer Diagrams
Risk Management
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SAS Drug Formulation Stability Program
Seniors
Shortages, Drugs
Small Business
Spanish Language Materials
Stakeholders
Statistics, see Pharmacoepidemiology
and Statistical Science, Office of
Substance Abuse Treatment Facility Locator
Surveillance, Post-Marketing
Surveillance, Pharmaceutical Industry
Suitability Petitions
Sunscreen Citizen Petition Response Final
Rule
Synthetic Generic Conjugated Estrogens
Back to Top Back to Site Information
PDF requires the free Adobe Acrobat Reader
Date created: January 31, 2007, Last updated: October 24, 2007 |